Kenneth W O'keefe - Net Worth and Insider Trading

Kenneth W O'keefe Net Worth

The estimated net worth of Kenneth W O'keefe is at least $3 Million dollars as of 2024-04-27. Kenneth W O'keefe is the Director of Jazz Pharmaceuticals PLC and owns about 29,168 shares of Jazz Pharmaceuticals PLC (JAZZ) stock worth over $3 Million. Details can be seen in Kenneth W O'keefe's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Kenneth W O'keefe has not made any transactions after 2023-08-14 and currently still holds the listed stock(s).

Transaction Summary of Kenneth W O'keefe

To

Kenneth W O'keefe Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Kenneth W O'keefe owns 1 companies in total, including Jazz Pharmaceuticals PLC (JAZZ) .

Click here to see the complete history of Kenneth W O'keefe’s form 4 insider trades.

Insider Ownership Summary of Kenneth W O'keefe

Ticker Comapny Transaction Date Type of Owner
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 director

Kenneth W O'keefe Latest Holdings Summary

Kenneth W O'keefe currently owns a total of 1 stock. Kenneth W O'keefe owns 29,168 shares of Jazz Pharmaceuticals PLC (JAZZ) as of August 14, 2023, with a value of $3 Million.

Latest Holdings of Kenneth W O'keefe

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
JAZZ Jazz Pharmaceuticals PLC 2023-08-14 29,168 109.46 3,192,729

Holding Weightings of Kenneth W O'keefe


Kenneth W O'keefe Form 4 Trading Tracker

According to the SEC Form 4 filings, Kenneth W O'keefe has made a total of 8 transactions in Jazz Pharmaceuticals PLC (JAZZ) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Jazz Pharmaceuticals PLC is the sale of 1,241 shares on August 14, 2023, which brought Kenneth W O'keefe around $171,457.

Insider Trading History of Kenneth W O'keefe

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Kenneth W O'keefe Trading Performance

GuruFocus tracks the stock performance after each of Kenneth W O'keefe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Kenneth W O'keefe is 18.54%. GuruFocus also compares Kenneth W O'keefe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth W O'keefe within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Kenneth W O'keefe's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Kenneth W O'keefe

Average Return

18.94%

Average return per transaction

Outperforming Transactions

100%

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -8.39 18.54 36.27 18.94 12.09 5.84
Relative Return to S&P 500(%) -12.51 10.53 25.79 -0.22 0.36 -6.84

Kenneth W O'keefe Ownership Network

Ownership Network List of Kenneth W O'keefe

No Data

Ownership Network Relation of Kenneth W O'keefe


Kenneth W O'keefe Owned Company Details

What does Jazz Pharmaceuticals PLC do?

Who are the key executives at Jazz Pharmaceuticals PLC?

Kenneth W O'keefe is the director of Jazz Pharmaceuticals PLC. Other key executives at Jazz Pharmaceuticals PLC include VP & Finance& PAO Patricia Carr , SVP & General Counsel Neena M Patil , and director & 10 percent owner Patrick G Enright .

Jazz Pharmaceuticals PLC (JAZZ) Insider Trades Summary

Over the past 18 months, Kenneth W O'keefe made 2 insider transaction in Jazz Pharmaceuticals PLC (JAZZ) with a net sale of 3,931. Other recent insider transactions involving Jazz Pharmaceuticals PLC (JAZZ) include a net sale of 6,364 shares made by Patricia Carr , a net sale of 7,360 shares made by Neena M Patil , and a net sale of 7,000 shares made by Bruce C Cozadd .

In summary, during the past 3 months, insiders sold 3,704 shares of Jazz Pharmaceuticals PLC (JAZZ) in total and bought 12,000 shares, with a net purchase of 8,296 shares. During the past 18 months, 64,701 shares of Jazz Pharmaceuticals PLC (JAZZ) were sold and 12,000 shares were bought by its insiders, resulting in a net sale of 52,701 shares.

Jazz Pharmaceuticals PLC (JAZZ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Jazz Pharmaceuticals PLC Insider Transactions

No Available Data

Kenneth W O'keefe Mailing Address

Above is the net worth, insider trading, and ownership report for Kenneth W O'keefe. You might contact Kenneth W O'keefe via mailing address: C/o Beecken Petty O'keefe & Company, 131 S. Dearborn Street, Suite 2800, Chicago Il 60603.

Discussions on Kenneth W O'keefe

No discussions yet.